Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CASI will rise by +152.43% over the next 2 Weeks and hit $0.38 by Wednesday, March 11, 2026. In that time frame, CASI's share price is expected to range between $0.27 and $0.49.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 11, 2026 | 0.40 | 0.55 | 0.69 |
| Mar 10, 2026 | 0.50 | 0.64 | 0.78 |
| Mar 9, 2026 | 0.56 | 0.69 | 0.82 |
| Mar 6, 2026 | 0.56 | 0.69 | 0.82 |
| Mar 5, 2026 | 0.56 | 0.69 | 0.83 |
| Mar 4, 2026 | 0.46 | 0.60 | 0.73 |
| Mar 3, 2026 | 0.55 | 0.69 | 0.83 |
| Mar 2, 2026 | 0.61 | 0.74 | 0.88 |
| Feb 27, 2026 | 0.61 | 0.74 | 0.87 |
| Feb 26, 2026 | 0.60 | 0.74 | 0.86 |
CASI shares rose +3.08% in Tuesday, March 17, 2026's trading session, rising from a previous close of $0.15 to move at $0.15. The stock demonstrated notable intraday movement (see CASI's key stats for a full breakdown), fluctuating between $0.15 and $0.15, a +0.33% trading range. While recent weeks have seen some volatility, CASI has managed to secure a -80.45% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 7.36M shares changing hands, 7.34M more than the previous session. This amounted to $1.11M in total market activity.
Will CASI Continue Its Upward Trend?
According to analyst ratings and projections for CASI, CASI Pharmaceuticals, Inc. shares are anticipated to increase by +78.04%, potentially reaching $0.69 per share by March 11, 2026. Short-term technical indicators currently suggest a bullish sentiment for CASI. However, the stock has recorded 19 negative trading days within the past 30 sessions. Based on the CASI stock forecast, now is a good time to buy CASI stock because its current trading price is -72.50% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CASI covering social and institutional perspectives.
CASI Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CASI's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 35.60% to 47.72%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 36.15%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 40.77%, maintains a neutral outlook for the long term. Insights into CASI's shareholder base show how institutional investors are positioning themselves during these momentum shifts
CASI Pharmaceuticals Short-Term Forecasts
CASI Forecast For Next 5 Days
Our algorithm anticipates CASI Pharmaceuticals (CASI) stock could hit $0.67 by Mar 27, 2026. This represents a +344.25% fall from today's price, following a -8.33% change over the past five days.
CASI Forecast For Next 30 Days
Based on analysis of market trends, the outlook for CASI Pharmaceuticals, Inc. (CASI) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.75, which would mean a +398.34% increase from the current price of $0.15. Projections for this period range from a high of $1.00 to a low of $0.52.
CASI Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for CASI Pharmaceuticals's price over the next three months point to a rise. CASI stock is expected to peak at $1.22 on May 28, 2026 before potentially dipping to $0.00 on Aug 20, 2026. On average, CASI is likely to trade around $1.18 in the coming 90 days.
CASI Pharmaceuticals Stock Forecast 2025
Based on our predictive models, CASI Pharmaceuticals (CASI) is expected to trade between $0.00 and $2.14 throughout 2026. This would result in an average price of $1.04, potentially offering investors a +591.03% return from current levels.
CASI Pharmaceuticals, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, CASI Pharmaceuticals, Inc. (CASI) is positioned to show a strong performance in March 2026. The price is predicted to move between $1.56 and $2.14, settling at an average of $1.90. This could translate to a +1,162.46% gain.
April 2026
Based on current market signals, CASI Pharmaceuticals, Inc. is projected to trend april 2026. We forecast a trading range from $0.51 to $1.76, with a likely average price of $1.21. Investors could expect a potential return of +703.99%.
May 2026
Our predictive algorithms indicate CASI Pharmaceuticals, Inc. stock may see a shift in May 2026. The expected range spans $0.47–$1.22, with an average target of $0.90. This represents a positive outlook and a possible gain of +498.01%.
June 2026
Analyzing established trends, CASI Pharmaceuticals, Inc. looks set to move in June 2026. Projections place the stock between $0.26 and $1.16, averaging around $1.12. This suggests a +644.19% gain from current levels.
July 2026
Market indicators suggest CASI Pharmaceuticals, Inc. could experience notable changes during July 2026. Prices could fluctuate within $0.00 to $0.77, with a midpoint forecast of $1.18. The stock might deliver a +684.05% gain.
August 2026
Forecasting for August 2026, models estimate that CASI Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.38, averaging $1.30. This signals a positive trajectory with potential returns around +763.79%.
September 2026
According to our latest forecast models, CASI Pharmaceuticals, Inc. (CASI) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $0.00, settling at an average of $1.00. This could translate to a +564.45% gain.
October 2026
Based on current market signals, CASI Pharmaceuticals, Inc. is projected to trend october 2026. We forecast a trading range from $0.00 to $0.00, with a likely average price of $0.85. Investors could expect a potential return of +464.78%.
November 2026
Our predictive algorithms indicate CASI Pharmaceuticals, Inc. stock may see a shift in November 2026. The expected range spans $0.00–$0.00, with an average target of $0.89. This represents a positive outlook and a possible gain of +491.36%.
December 2026
Analyzing established trends, CASI Pharmaceuticals, Inc. looks set to move in December 2026. Projections place the stock between $0.00 and $0.00, averaging around $0.62. This suggests a +311.96% gain from current levels.
January 2027
Market indicators suggest CASI Pharmaceuticals, Inc. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.56. The stock might deliver a +272.09% gain.
February 2027
Forecasting for February 2027, models estimate that CASI Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.36. This signals a positive trajectory with potential returns around +139.20%.
CASI's history of dividends and stock splits also plays a role in long-term investor confidence.

